138 related articles for article (PubMed ID: 30824201)
1. Structure-activity relationship studies of Bz amide-containing α-GalCer derivatives as natural killer T cell modulators.
Kishi J; Inuki S; Hirata N; Kashiwabara E; Yoshidome D; Ichihara O; Fujimoto Y
Bioorg Med Chem Lett; 2019 Apr; 29(8):970-973. PubMed ID: 30824201
[TBL] [Abstract][Full Text] [Related]
2. Design and Discovery of Covalent α-GalCer Derivatives as Potent CD1d Ligands.
Kishi J; Inuki S; Kashiwabara E; Suzuki T; Dohmae N; Fujimoto Y
ACS Chem Biol; 2020 Feb; 15(2):353-359. PubMed ID: 31939653
[TBL] [Abstract][Full Text] [Related]
3. Polar functional group-containing glycolipid CD1d ligands modulate cytokine-biasing responses and prevent experimental colitis.
Inuki S; Hirata N; Kashiwabara E; Kishi J; Aiba T; Teratani T; Nakamura W; Kojima Y; Maruyama T; Kanai T; Fujimoto Y
Sci Rep; 2020 Sep; 10(1):15766. PubMed ID: 32978421
[TBL] [Abstract][Full Text] [Related]
4. Introduction of aromatic group on 4'-OH of α-GalCer manipulated NKT cell cytokine production.
Zhang W; Xia C; Nadas J; Chen W; Gu L; Wang PG
Bioorg Med Chem; 2011 Apr; 19(8):2767-76. PubMed ID: 21439833
[TBL] [Abstract][Full Text] [Related]
5. Isolated Polar Amino Acid Residues Modulate Lipid Binding in the Large Hydrophobic Cavity of CD1d.
Inuki S; Aiba T; Hirata N; Ichihara O; Yoshidome D; Kita S; Maenaka K; Fukase K; Fujimoto Y
ACS Chem Biol; 2016 Nov; 11(11):3132-3139. PubMed ID: 27648599
[TBL] [Abstract][Full Text] [Related]
6. Galactosylsphingamides: new α-GalCer analogues to probe the F'-pocket of CD1d.
Guillaume J; Wang J; Janssens J; Remesh SG; Risseeuw MDP; Decruy T; Froeyen M; Elewaut D; Zajonc DM; Calenbergh SV
Sci Rep; 2017 Jun; 7(1):4276. PubMed ID: 28655912
[TBL] [Abstract][Full Text] [Related]
7. Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine production.
Wojno J; Jukes JP; Ghadbane H; Shepherd D; Besra GS; Cerundolo V; Cox LR
ACS Chem Biol; 2012 May; 7(5):847-55. PubMed ID: 22324848
[TBL] [Abstract][Full Text] [Related]
8. NKT TCR recognition of CD1d-α-C-galactosylceramide.
Patel O; Cameron G; Pellicci DG; Liu Z; Byun HS; Beddoe T; McCluskey J; Franck RW; Castaño AR; Harrak Y; Llebaria A; Bittman R; Porcelli SA; Godfrey DI; Rossjohn J
J Immunol; 2011 Nov; 187(9):4705-13. PubMed ID: 21964029
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of a 2"-deoxy-β-GalCer.
Thakur MS; Khurana A; Kronenberg M; Howell AR
Molecules; 2014 Jul; 19(7):10090-102. PubMed ID: 25014535
[TBL] [Abstract][Full Text] [Related]
10. Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.
Schiefner A; Fujio M; Wu D; Wong CH; Wilson IA
J Mol Biol; 2009 Nov; 394(1):71-82. PubMed ID: 19732779
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.
Jervis PJ; Polzella P; Wojno J; Jukes JP; Ghadbane H; Garcia Diaz YR; Besra GS; Cerundolo V; Cox LR
Bioconjug Chem; 2013 Apr; 24(4):586-94. PubMed ID: 23458425
[TBL] [Abstract][Full Text] [Related]
12. Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy.
Wu TN; Lin KH; Chang YJ; Huang JR; Cheng JY; Yu AL; Wong CH
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17275-80. PubMed ID: 21987790
[TBL] [Abstract][Full Text] [Related]
13. Potent Th2 Cytokine Bias of Natural Killer T Cell by CD1d Glycolipid Ligands: Anchoring Effect of Polar Groups in the Lipid Component.
Inuki S; Kashiwabara E; Hirata N; Kishi J; Nabika E; Fujimoto Y
Angew Chem Int Ed Engl; 2018 Jul; 57(31):9655-9659. PubMed ID: 29863807
[TBL] [Abstract][Full Text] [Related]
14. Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors.
Pellicci DG; Clarke AJ; Patel O; Mallevaey T; Beddoe T; Le Nours J; Uldrich AP; McCluskey J; Besra GS; Porcelli SA; Gapin L; Godfrey DI; Rossjohn J
Nat Immunol; 2011 Jul; 12(9):827-33. PubMed ID: 21804559
[TBL] [Abstract][Full Text] [Related]
15. Endocytic pH regulates cell surface localization of glycolipid antigen loaded CD1d complexes.
Arora P; Kharkwal SS; Ng TW; Kunnath-Velayudhan S; Saini NK; Johndrow CT; Chang YT; Besra GS; Porcelli SA
Chem Phys Lipids; 2015 Oct; 191():75-83. PubMed ID: 26306469
[TBL] [Abstract][Full Text] [Related]
16. 4,5-cis unsaturated α-GalCer analogues distinctly lead to CD1d-mediated Th1-biased NKT cell responses.
Cui Y; Li Z; Cheng Z; Xia C; Zhang Y
Chem Res Toxicol; 2015 Jun; 28(6):1209-15. PubMed ID: 25955524
[TBL] [Abstract][Full Text] [Related]
17. Glycolipids that elicit IFN-γ-biased responses from natural killer T cells.
Tyznik AJ; Farber E; Girardi E; Birkholz A; Li Y; Chitale S; So R; Arora P; Khurana A; Wang J; Porcelli SA; Zajonc DM; Kronenberg M; Howell AR
Chem Biol; 2011 Dec; 18(12):1620-30. PubMed ID: 22195564
[TBL] [Abstract][Full Text] [Related]
18. A molecular switch in mouse CD1d modulates natural killer T cell activation by α-galactosylsphingamides.
Wang J; Guillaume J; Janssens J; Remesh SG; Ying G; Bitra A; Van Calenbergh S; Zajonc DM
J Biol Chem; 2019 Sep; 294(39):14345-14356. PubMed ID: 31391251
[TBL] [Abstract][Full Text] [Related]
19. In contrast to other species, α-Galactosylceramide (α-GalCer) is not an immunostimulatory NKT cell agonist in horses.
Dossa RG; Alperin DC; Garzon D; Mealey RH; Brown WC; Jervis PJ; Besra GS; Cox LR; Hines SA
Dev Comp Immunol; 2015 Mar; 49(1):49-58. PubMed ID: 25445911
[TBL] [Abstract][Full Text] [Related]
20. New CD1d agonists: synthesis and biological activity of 6″-triazole-substituted α-galactosyl ceramides.
Jervis PJ; Graham LM; Foster EL; Cox LR; Porcelli SA; Besra GS
Bioorg Med Chem Lett; 2012 Jul; 22(13):4348-52. PubMed ID: 22652050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
